FI106259B - Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI106259B FI106259B FI942310A FI942310A FI106259B FI 106259 B FI106259 B FI 106259B FI 942310 A FI942310 A FI 942310A FI 942310 A FI942310 A FI 942310A FI 106259 B FI106259 B FI 106259B
- Authority
- FI
- Finland
- Prior art keywords
- phenyl
- methyl
- compound
- tetrahydro
- cyclohexen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Luminescent Compositions (AREA)
- Manufacture Of Tobacco Products (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI980471A FI107383B (fi) | 1991-11-20 | 1998-03-02 | Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79520791A | 1991-11-20 | 1991-11-20 | |
US79520791 | 1991-11-20 | ||
US07/957,277 US5314896A (en) | 1991-11-20 | 1992-10-15 | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
US95727792 | 1992-10-15 | ||
PCT/US1992/009583 WO1993010092A1 (en) | 1991-11-20 | 1992-11-05 | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
US9209583 | 1992-11-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI942310A0 FI942310A0 (fi) | 1994-05-18 |
FI942310A FI942310A (fi) | 1994-07-15 |
FI106259B true FI106259B (fi) | 2000-12-29 |
Family
ID=27121601
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI942310A FI106259B (fi) | 1991-11-20 | 1994-05-18 | Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi |
FI980471A FI107383B (fi) | 1991-11-20 | 1998-03-02 | Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI980471A FI107383B (fi) | 1991-11-20 | 1998-03-02 | Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi |
Country Status (20)
Country | Link |
---|---|
US (2) | US5314896A (cs) |
EP (2) | EP0613465B1 (cs) |
JP (1) | JP3193718B2 (cs) |
KR (1) | KR100234600B1 (cs) |
AT (1) | ATE206398T1 (cs) |
AU (1) | AU664872B2 (cs) |
CA (1) | CA2122911C (cs) |
CZ (1) | CZ284181B6 (cs) |
DE (1) | DE69232099T2 (cs) |
DK (1) | DK0613465T3 (cs) |
ES (1) | ES2165360T3 (cs) |
FI (2) | FI106259B (cs) |
HU (1) | HU218935B (cs) |
NO (1) | NO180632C (cs) |
NZ (1) | NZ245174A (cs) |
PT (1) | PT613465E (cs) |
RU (1) | RU2116297C1 (cs) |
SG (1) | SG46641A1 (cs) |
SK (1) | SK280812B6 (cs) |
WO (1) | WO1993010092A1 (cs) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5401692A (en) * | 1993-06-15 | 1995-03-28 | Texas Instruments Incorporated | Method for minimizing particle generation on a wafer surface during high pressure oxidation of silicon |
US5468768A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antimigraine derivatives of indolylcycloalkanylamines |
US5468767A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives |
US5710277A (en) * | 1994-09-12 | 1998-01-20 | Warner-Lambert Company | Process for R (+) 1,2,3,6-tetrahydro-4-phenyl-1- (3-phenyl-3-cyclohexen-1-yl)methyl!pyridine, a central nervous system agent |
JP3332929B2 (ja) * | 1995-02-15 | 2002-10-07 | ニューロゲン コーポレイション | ある種の架橋4−フェニル−2−アミノメチルイミダゾール:新しいドパミン受容体サブタイプ特異的リガンド |
US5773616A (en) * | 1995-02-15 | 1998-06-30 | Neurogen Corporation | Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands |
WO1996029330A1 (fr) * | 1995-03-22 | 1996-09-26 | Taisho Pharmaceutical Co., Ltd. | Derives de la thiazole |
US6245768B1 (en) | 1995-06-05 | 2001-06-12 | Neurogen Corporation | 1-(N′-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands |
US5656632A (en) * | 1995-06-05 | 1997-08-12 | Neurogen Corporation | 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligands |
US5602168A (en) * | 1995-07-10 | 1997-02-11 | Neurogen Corporation | 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligands |
US5633724A (en) * | 1995-08-29 | 1997-05-27 | Hewlett-Packard Company | Evanescent scanning of biochemical array |
GB9523462D0 (en) * | 1995-11-16 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
CA2327303A1 (en) * | 1998-04-08 | 1999-10-14 | American Home Products Corporation | N-aryloxyethylamine derivatives for the treatment of depression |
ES2182775T3 (es) * | 1999-01-07 | 2003-03-16 | Wyeth Corp | Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion. |
US6313126B1 (en) | 1999-01-07 | 2001-11-06 | American Home Products Corp | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
US6200994B1 (en) | 1999-01-07 | 2001-03-13 | American Home Products Corp | 1,4-Disubstituted cyclohexane derivatives for the treatment of depression |
US6245780B1 (en) * | 1999-04-22 | 2001-06-12 | American Home Products Corp | Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression |
KR100634039B1 (ko) | 1999-08-23 | 2006-10-17 | 솔베이 파마슈티칼스 비. 브이 | 신규한 페닐피페라진 |
US6780305B2 (en) * | 2001-02-20 | 2004-08-24 | Fuji Photo Film Co., Ltd. | Method for producing support for planographic printing plate, support for planographic printing plate, and planographic printing plate precursor |
AR032712A1 (es) * | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
US20040197284A1 (en) | 2003-04-04 | 2004-10-07 | Frederic Auguste | Cosmetic composition comprising a volatile fatty phase |
AR047759A1 (es) | 2003-09-26 | 2006-02-22 | Vertex Pharma | Derivados de fenil - piperazina como moduladores de receptores muscarnicos |
US8217027B2 (en) | 2006-12-21 | 2012-07-10 | Abbott Laboratories | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
CA2673076A1 (en) | 2006-12-21 | 2008-07-03 | Abbott Laboratories | Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane carboxylates |
CL2007003784A1 (es) * | 2006-12-21 | 2008-06-27 | Abbott Lab | Compuestos derivados de 1-amino-3-fenilciclopentano, que son agonistas o antagonistas de uno o mas receptores de la familia s1p; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar la esclerosis multiple, artritis reumato |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4597921A (en) * | 1984-07-26 | 1986-07-01 | Northern Telecom Limited | Provision of plastic insulation upon an electrical conductor |
US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
US4975445A (en) * | 1989-12-06 | 1990-12-04 | Warner-Lambert Company | Substituted cyclohexenes as central nervous system agents |
US4957921A (en) * | 1989-12-06 | 1990-09-18 | Warner-Lambert Company | Substituted cyclohexanols as central nervous system agents |
US5124332A (en) * | 1991-01-28 | 1992-06-23 | Warner-Lambert Company | Substituted indoles as central nervous system agents |
-
1992
- 1992-10-15 US US07/957,277 patent/US5314896A/en not_active Expired - Fee Related
- 1992-11-05 ES ES92925105T patent/ES2165360T3/es not_active Expired - Lifetime
- 1992-11-05 DK DK92925105T patent/DK0613465T3/da active
- 1992-11-05 KR KR1019940701684A patent/KR100234600B1/ko not_active IP Right Cessation
- 1992-11-05 SK SK569-94A patent/SK280812B6/sk unknown
- 1992-11-05 DE DE69232099T patent/DE69232099T2/de not_active Expired - Fee Related
- 1992-11-05 RU RU94028888/04A patent/RU2116297C1/ru not_active IP Right Cessation
- 1992-11-05 SG SG1996006952A patent/SG46641A1/en unknown
- 1992-11-05 CZ CZ941161A patent/CZ284181B6/cs not_active IP Right Cessation
- 1992-11-05 EP EP92925105A patent/EP0613465B1/en not_active Expired - Lifetime
- 1992-11-05 AT AT92925105T patent/ATE206398T1/de not_active IP Right Cessation
- 1992-11-05 CA CA002122911A patent/CA2122911C/en not_active Expired - Fee Related
- 1992-11-05 PT PT92925105T patent/PT613465E/pt unknown
- 1992-11-05 EP EP92118998A patent/EP0545095A1/en active Pending
- 1992-11-05 JP JP50933393A patent/JP3193718B2/ja not_active Expired - Fee Related
- 1992-11-05 AU AU31291/93A patent/AU664872B2/en not_active Ceased
- 1992-11-05 WO PCT/US1992/009583 patent/WO1993010092A1/en active IP Right Grant
- 1992-11-05 HU HU9401468A patent/HU218935B/hu not_active IP Right Cessation
- 1992-11-18 NZ NZ245174A patent/NZ245174A/en unknown
-
1994
- 1994-02-04 US US08/192,238 patent/US5409931A/en not_active Expired - Fee Related
- 1994-05-18 FI FI942310A patent/FI106259B/fi not_active IP Right Cessation
- 1994-05-19 NO NO941884A patent/NO180632C/no not_active IP Right Cessation
-
1998
- 1998-03-02 FI FI980471A patent/FI107383B/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI106259B (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi | |
AU2015335694B2 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
JP2868313B2 (ja) | N−置換複素環誘導体およびその製法 | |
AU782763B2 (en) | Cyclic amidine compounds | |
AU771920B2 (en) | Heterocyclic compounds having effect of activating nicotinic acetylcholine alpha4beta2 receptor | |
AU5567000A (en) | Alpha1b-adrenergic receptor antagonists | |
CA2596393A1 (en) | 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions | |
CA2188427C (en) | Neurotransmitter release enhancers | |
US6900202B2 (en) | Di-substituted imineheterocyclic compounds | |
EP3558965A1 (en) | New quinoline and isoquinoline derivatives for treating pain and pain related conditions | |
NO338104B1 (no) | Tetrahydroisoquinolin-sulfonamid-derivater, farmasøytiske preparater inneholdende slike og anvendelse derav som terapeutisk middel | |
CA2781858C (en) | Modulators of tnf-.alpha. signaling | |
NO313196B1 (no) | Pyrimidinylpyrazol-derivat, og antitumormiddel inneholdende dette | |
US6630469B2 (en) | 5-HT7 receptor antagonists | |
DK156722B (da) | Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater | |
KR100425953B1 (ko) | 티오피란유도체 | |
BG108531A (bg) | Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван... | |
AU600378B2 (en) | Piperidine derivatives, their preparation and their application in therapy | |
IE66117B1 (en) | Substituted cyclohexenes as central nervous system agents | |
CA2141810A1 (en) | Amide derivatives | |
CZ46896A3 (en) | Anti-migraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and -pyrimidinyl piperazines | |
AU782771B2 (en) | Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholine receptors activators | |
SK17122002A3 (sk) | Derivát heterocyklického aminoalkylpyridínu ako psychofarmaceutické činidlo, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
US5089497A (en) | Substituted piperazines as central nervous system agents | |
Paluchowska et al. | Modification of the structure of 4, 6‐disubstituted 2‐(4‐alkyl‐1‐piperazinyl) pyridines: synthesis and their 5‐HT2A receptor activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |